MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Optimizing Treatment of Stage IV Breast Cancer Through Real-Time Disease Monitoring
Suspended
- Conditions
- Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8
- Interventions
- Procedure: Biospecimen Collection
- First Posted Date
- 2021-05-28
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 150
- Registration Number
- NCT04906369
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy
Not Applicable
Withdrawn
- Conditions
- Hypertrophic CardiomyopathyCardiomyopathy, HypertrophicHypertrophic Obstructive Cardiomyopathy
- Interventions
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- Mayo Clinic
- Registration Number
- NCT04905173
Cellular Senescence and COVID-19 Long-Hauler Syndrome
- Conditions
- SARS-CoV2 Infection
- First Posted Date
- 2021-05-26
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 200
- Registration Number
- NCT04903132
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis
Early Phase 1
Completed
- Conditions
- Aortic StenosisTransthyretin AmyloidosisTransthyretin Amyloid CardiomyopathyTransthyretin Cardiac Amyloidosis
- Interventions
- Drug: 99mTc-PYP
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT04899180
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Noninvasive Evaluation of Renal Allograft Fibrosis by MRI
Not Applicable
Completed
- Conditions
- Kidney Transplantation
- Interventions
- Other: MRI 1.5T and 3.0T
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 22
- Registration Number
- NCT04899167
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Eosinophils in Human Adipose Tissue
Not Applicable
- Conditions
- Insulin ResistanceObesity
- Interventions
- Procedure: endoscopy sleeve gastroplasty
- First Posted Date
- 2021-05-24
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT04898400
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
A Study to Evaluate the Effects of Sharpened Romberg Testing (SRT) in Healthy Subjects
Not Applicable
Completed
- Conditions
- HypocapniaBalance; Distorted
- Interventions
- Behavioral: Increased breathingOther: sharpened Romberg test (SRT)
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT04897360
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Active Older Adult Program on Health and Well-being
Completed
- Conditions
- Older Adult
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 33
- Registration Number
- NCT04897373
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer
Active, not recruiting
- Conditions
- Invasive Breast Carcinoma
- Interventions
- Procedure: Biospecimen Collection
- First Posted Date
- 2021-05-21
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT04897009
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
Phase 2
Recruiting
- Conditions
- Metastatic Salivary Gland CarcinomaStage IV Major Salivary Gland Cancer AJCC v8Adenoid Cystic CarcinomaRecurrent Salivary Gland Carcinoma
- Interventions
- Biological: PembrolizumabDrug: Pemetrexed DisodiumProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Positron Emission TomographyProcedure: Magnetic Resonance ImagingProcedure: PSMA PET Scan
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2024-06-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 45
- Registration Number
- NCT04895735
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath